
For research use only. We do not supply to patients.
For pharmaceutical-grade products or other inquiries, please contact our experts.
Bentonite is an appropriate excipient, which is considered Montmorillonite (MMT) for developing drug carriers with excellent physicochemical properties. Drug molecules intercalate into interlayers of MMT because of the high cation exchange capacity and large specific surface area. Intercalation of drugs into MMT was confirmed by an ion-exchange reaction between sodium ions in the interlayer of clay and TM molecules. Ion-exchange reaction occurred rapidly within an hour.
In vitrol release studies showed that drug release from MMT hybrid in simulated gastric and intestinal fluids is sustained and controlled. There is not burst effect of TM, but a gradual drug release pattern is observed. Release of TM from MMT is found to be slow. Such incomplete release is due to an interplay of ion-exchange between the intercalated TM and the buffer ions and electrostatic attraction with the negatively charged solid surface. MMT has proven itself to be a suitable drug carrier as it can greatly improve the pharmacological efficacy of the entrapped drug molecules by providing them with controlled release attributes.
Fig. 1 Possible structural arrangement of MMT–TM. (Joshi G V, et al. 2009)
References
Hydrogels show great potential as wound dressings. However, conventional hydrogels often lack mechanical strength and antimicrobial activity. Ebrahimnejad P et al. developed a new sodium alginate-based metformin-loaded bentonite (Met-Ben) nanocomposite hydrogel with improved properties for wound healing applications. The nanocomposite hydrogel showed improved mechanical properties, swelling behavior, and controlled drug release.
Metformin was loaded into bentonite nanoparticles using the ion exchange method with an entrapment efficiency of 75.6% and drug loading of 27.7%. The loading of Metformin not only provided controlled release of the drug but also accelerated wound healing by modulating inflammation and promoting collagen synthesis. The in vivo results showed accelerated wound closure (85% at day 14), increased collagen deposition, and improved fibroblast maturation, re-epithelialization, and neovascularization compared to the control. The gene expression analysis also revealed downregulation of TNF-α and IL-1β and upregulation of TGF-β, indicating the modulation of inflammation and promotion of tissue regeneration.
Fig. 2 Metformin/bentonite nanocomposite hydrogel for enhanced wound healing. (Ebrahimnejad P, et al. 2025)
References
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
All our products are chemicals for research purposes only. We do not supply for human or veterinary applications.
Privacy Policy | Cookie Policy Copyright © Protheragen. All Rights Reserved.
